EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eutilex Co's enterprise value is ₩59,142.1 Mil.
Eutilex Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩410.2 Mil. Therefore, Eutilex Co's EV-to-Revenue for today is 144.19.
The historical rank and industry rank for Eutilex Co's EV-to-Revenue or its related term are showing as below:
XKRX:263050'
s EV-to-Revenue Range Over the Past 10 Years
Min: 147.62 Med: 837.56 Max: 4949.1
Current: 144.18
During the past 9 years, the highest EV-to-Revenue of Eutilex Co was 4949.10. The lowest was 147.62. And the median was 837.56.
XKRX:263050's EV-to-Revenue is ranked worse than 86.02% of 1037
companies
in the Biotechnology industry
Industry Median: 7.86
vs XKRX:263050: 144.18
As of today (2024-06-08), Eutilex Co's stock price is ₩2100.00.
Eutilex Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩11.16. Therefore, Eutilex Co's PS Ratio for today is 188.17.
Eutilex Co EV-to-Revenue Historical Data
The historical data trend for Eutilex Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eutilex Co's EV-to-Revenue
For the Biotechnology subindustry, Eutilex Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eutilex Co's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Eutilex Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Eutilex Co's EV-to-Revenue falls into.
Eutilex Co's current Enterprise Value is ₩59,142.1 Mil.
Eutilex Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩410.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eutilex Co (XKRX:263050) EV-to-Revenue Explanation
Eutilex Co's share price for today is ₩2100.00.
Eutilex Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩11.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eutilex Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Eutilex Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:263050 has been successfully added to your 